Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Buprenorphine Dosing in Opioid Use Disorder
NCT04091009Phase 4Withdrawn
- Sponsor
- Massachusetts General Hospital
- Start
- Oct 2019
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of buprenorphine in opioid use disorder (OUD), sponsored by Massachusetts General Hospital. Planned start Oct 2019; status: withdrawn.
02
Drugs
buprenorphine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT04091009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04091009.